2/6
03:35 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/29
02:01 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/21
02:02 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/13
02:11 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
1/6
06:06 pm
mrns
MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS
Low
Report
MARINUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marinus Pharmaceuticals, Inc. - MRNS
1/6
09:07 am
mrns
Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm
Low
Report
Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm
1/5
02:14 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
12/30
05:20 pm
mrns
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Marinus Pharmaceuticals, Inc. - MRNS
Low
Report
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Marinus Pharmaceuticals, Inc. - MRNS
12/30
09:43 am
mrns
Shareholder Alert: Ademi LLP Investigates Whether Marinus Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Low
Report
Shareholder Alert: Ademi LLP Investigates Whether Marinus Pharmaceuticals, Inc. Is Obtaining a Fair Price for Its Public Shareholders
12/30
09:08 am
mrns
MRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Marinus Pharmaceuticals, Inc. Is Fair to Shareholders
Low
Report
MRNS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Marinus Pharmaceuticals, Inc. Is Fair to Shareholders
12/30
07:12 am
mrns
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. [Yahoo! Finance]
High
Report
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. [Yahoo! Finance]
12/30
07:12 am
mrns
Orion and Marinus terminate agreement for ganaxolone in Europe [Yahoo! Finance]
Medium
Report
Orion and Marinus terminate agreement for ganaxolone in Europe [Yahoo! Finance]
12/30
07:09 am
mrns
Immedica to buy Marinus Pharmaceuticals, stock rises 4% [Seeking Alpha]
High
Report
Immedica to buy Marinus Pharmaceuticals, stock rises 4% [Seeking Alpha]
12/30
07:00 am
mrns
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
High
Report
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
12/28
02:12 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/20
02:03 am
mrns
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.